Bernitsas Law advised Partners Group and Pharmathen in connection with the financing of the acquisition of CBL Patras by Pharmathen.
The acquisition of CBL Patras marks an important milestone that will create synergies through vertical integration and expansion of the product portfolio for both companies.
This acquisition underscores the commitment of Partners Group in Pharmathen's ongoing evolution plan and the active participation of Pharmathen in the strategic growth and expansion of the Greek pharmaceutical industry.
CBL Patras is a leading FDA-approved peptide manufacturer and supplier in Europe.
Partners Group is a global private equity firm. Pharmathen is a leading complex drug delivery and formulation developer which ranks among the top 50 pharmaceutical research companies in Europe.
Partner Athanasia Tsene led the team advising on this transaction, assisted by Associate Sildia Fotopoulou on the financing. Partner Evi Kitsou assisted by Associate Martha Ntounou advised on the corporate aspects of the financing.
